These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
589 related articles for article (PubMed ID: 9890427)
21. Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): is it a marker for immunity? Hassoba HM; Terrault NA; el-Gohary AM; Scheffel C; Jou C; Brackett J; Hunt J; Lou SC; Wright TL J Med Virol; 1997 Dec; 53(4):354-60. PubMed ID: 9407383 [TBL] [Abstract][Full Text] [Related]
22. GBV-C/HGV infection in end-stage renal disease: a serological and virological survey. Fabrizi F; Lunghi G; Pozzi C; Colzani S; Tentori F; Del Vecchio L; Corti M; Pagano A; Locatelli F J Nephrol; 2000; 13(1):68-74. PubMed ID: 10720218 [TBL] [Abstract][Full Text] [Related]
23. Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients. López-Alcorocho JM; Barril G; Ortiz-Movilla N; Traver JA; Bartolomé J; Sanz P; Selgas R; Carreño V J Med Virol; 2001 Feb; 63(2):103-7. PubMed ID: 11170045 [TBL] [Abstract][Full Text] [Related]
24. Is hepatitis G/GB virus-C virus hepatotropic? Detection of hepatitis G/GB virus-C viral RNA in liver and serum. Fan X; Xu Y; Solomon H; Ramrakhiani S; Neuschwander-Tetri BA; Di Bisceglie AM J Med Virol; 1999 Jun; 58(2):160-4. PubMed ID: 10335864 [TBL] [Abstract][Full Text] [Related]
25. Prevalence and molecular epidemiology of GB virus C/hepatitis G virus infection in Mongolia. Kondo Y; Mizokami M; Nakano T; Kato T; Ueda R; Mukaide M; Hikiji K; Ishida T; Dorjsuren D; Dashnyam B; Oyunsuren T J Med Virol; 1997 Jun; 52(2):143-8. PubMed ID: 9179759 [TBL] [Abstract][Full Text] [Related]
26. [GBV-C/HGV, a new virus as one possible cause of hepatitis of unknown etiology]. König J; Summerová M; Kaslíková J; Svejda J; Strakrle V; Gregora E; Nĕmecek V; Procházka B; Rozprimová L; Rocková R Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):103-10. PubMed ID: 11550417 [TBL] [Abstract][Full Text] [Related]
27. A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. Brescia HCC Study. Tagger A; Donato F; Ribero ML; Chiesa R; Tomasoni V; Portera G; Gelatti U; Albertini A; Fasola M; Nardi G Hepatology; 1997 Dec; 26(6):1653-7. PubMed ID: 9398012 [TBL] [Abstract][Full Text] [Related]
28. [Investigation of hepatitis G virus prevalence in hemodialysis patients and blood donors in Denizli, Turkey]. Hanci SY; Cevahir N; Kaleli I; Hanci V Mikrobiyol Bul; 2008 Oct; 42(4):617-25. PubMed ID: 19149083 [TBL] [Abstract][Full Text] [Related]
30. Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populations. Nübling CM; Bialleck H; Fürsch AJ; Scharrer I; Schramm W; Seifried E; Schmidt U; Staszewski S; Löwer J J Med Virol; 1997 Nov; 53(3):218-24. PubMed ID: 9365885 [TBL] [Abstract][Full Text] [Related]
31. [The prevalence of hepatitis G virus in patients with hepatitis B and C virus infections]. Kaya S; Cicioğlu Aridoğan B; Demirci M Mikrobiyol Bul; 2004 Oct; 38(4):421-7. PubMed ID: 15700668 [TBL] [Abstract][Full Text] [Related]
32. [Serological and pathological follow-up studies of the patients with single GBV-C/HGV RNA infection]. Zhao J; Wang S; Xin S Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):16-9. PubMed ID: 12526295 [TBL] [Abstract][Full Text] [Related]
33. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652 [TBL] [Abstract][Full Text] [Related]
34. Gradual loss of IgG antibodies against GB virus C/hepatitis G virus in a patient with AIDS. Nerurkar VR; Chua PK; Shikuma CM; Dashwood WM; Milne CI; Woodward CL; Kobayashi G; Peterson JE; Yanagihara R Hawaii Med J; 1998 Dec; 57(12):733-4. PubMed ID: 9893387 [TBL] [Abstract][Full Text] [Related]
35. GB virus C/hepatitis G viremia and antibody response to the E2 protein of hepatitis G virus in hemodialysis patients. Okuda M; Hino K; Korenaga M; Yamaguchi Y; Katoh Y; Mukaide M; Kaneda Y; Minaminozono T; Okita K J Clin Gastroenterol; 2000 Jun; 30(4):425-8. PubMed ID: 10875473 [TBL] [Abstract][Full Text] [Related]
36. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood. Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643 [TBL] [Abstract][Full Text] [Related]
37. Genetic heterogeneity and molecular epidemiology of GB virus C/hepatitis G virus in China. An P; Luo H; Lu T; O'Brien SJ; Winkler C J Hum Virol; 2000; 3(6):299-305. PubMed ID: 11100910 [TBL] [Abstract][Full Text] [Related]
38. Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C. Yang JF; Dai CY; Chuang WL; Lin WY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML Jpn J Infect Dis; 2006 Feb; 59(1):25-30. PubMed ID: 16495630 [TBL] [Abstract][Full Text] [Related]
39. Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users. Anastassopoulou CG; Paraskevis D; Sypsa V; Psichogiou M; Katsoulidou A; Tassopoulos N; Skoutelis A; Malliori M; Hatzakis A J Med Virol; 1998 Nov; 56(3):246-52. PubMed ID: 9783693 [TBL] [Abstract][Full Text] [Related]
40. Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease. Tagger A; Ribero ML; Larghi A; Donato F; Zuin M; Chiesa R; Benetti G; Ramella G; Borzio M; Podda M Am J Gastroenterol; 1999 Feb; 94(2):484-8. PubMed ID: 10022651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]